CORCEPT THERAPEUTICS INC company info

CIK 1088856
IRS Number 770487658
State of incorporation DE
Business address 149 COMMONWEALTH DRIVE
None
MENLO PARK
CA
94025
Mail address 149 COMMONWEALTH DRIVE
None
MENLO PARK
CA
94025

Short summary

CORCEPT THERAPEUTICS INC is a California company, with head office located at 149 Commonwealth Drive Menlo Park, California 94025. The company achieved a record breaking net income in 2017 - 129.12 million USD. In 2018 the company owned a total of 320.21 million USD worth of assets, including 216.86 million USD worth of current assets. The company amassed the most assets last year, totalling up to 320.21 million USD.

CORCEPT THERAPEUTICS INC Income Statement

Name [in Millions USD]2000200120022003200420052006200720082009201020112012201320142015201620172018Trends
Revenue, Net 0.03
Cost of Goods and Services Sold 2.063.555.22
Selling, General and Administrative Expense 8.4911.3325.4131.2434.9236.9545.2462.4281.29
Research and development 14.4018.9521.0014.0720.4718.3715.4223.8440.3875.25
Operating Expenses 20.2827.4432.3339.5851.8554.17
Operating Income (Loss) -20.25-27.44-32.33-36.27-41.50-27.62-3.4410.1852.8689.50
Income Tax Expense (Benefit) 00-76.3216.74
Net income -1.85-7.45-18.50-9.81-15.54-20.09-24.87-11.57-20.06-20.17-25.97-32.35-38.05-46.01-31.38-6.418.14129.1275.41

CORCEPT THERAPEUTICS INC Balance Sheet

Name [in Millions USD]2000200120022003200420052006200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 14.7235.3952.2334.9072.2233.9737.0541.7933.6231.1749.65
Accounts Receivable, Net, Current 0.360.862.234.959.309.5028.7019.22
Inventories 2.440.691.071.452.133.094.955
Property, Plant and Equipment, Gross 0.080.230.350.530.460.660.911.28
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.050.080.150.290.370.450.390.63
Other Assets, Noncurrent 0.030.260.130.090.070.020.050.050.08
Total assets 52.7238.6279.6944.3948.3656.8486.54274.38320.21
Current assets 52.6938.3074.5739.4444.6954.7881.29197.18216.86
Accounts payable 2.294.243.032.602.362.082.086.379.33
Total current liabilities 3.865.829.0813.3017.4327.4320.3930.8734.22
Long-term Debt, Excluding Current Maturities 30.2427.6419.403.7400
Long-term Debt 4533.90
Total liabilities 29.5734.46
Common Stock, Value, Issued 0.080.090.100.100.110.110.110.120.12
Retained Earnings (Accumulated Deficit) -192.19-219.59-270.59-314.10-330.77-329.45-305.23-157.49-99.46
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.02-0.130.09

CORCEPT THERAPEUTICS INC Cash Flow

Name [in Millions USD]2000200120022003200420052006200720082009201020112012201320142015201620172018Trends
Net income -1.85-7.45-18.50-9.81-15.54-20.09-24.87-11.57-20.06-20.17-25.97-32.35-38.05-46.01-31.38-6.418.14129.1275.41
Depreciation and amortization 0.010.010.000.030.070.140.160.090.110.24
Deferred Income Tax Expense (Benefit) 00-76.7014.07
Accounts receivable 0.560.871.912.893.645.442.29
Inventories 4.660.88-0.25-0.820.682.267.78
Accounts payable -0.03-0.452.790.19-1.42-0.50-0.560.976.29-0.39
Deferred revenue 0.020.010.010.13-0.160
Net Cash Provided by (Used in) Operating Activities -17.97-22.29-27.40-36.02-37.0618.3960.94115.67
Payments to Acquire Property, Plant, and Equipment 0.030.150.130.170.020.190.420.30
Net Cash Provided by (Used in) Investing Activities 3.59-0.03-0.15-0.13-0.19-73.46-90.77
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.15-0.13-0.17-0.02-0.19-73.46
Proceeds from Issuance of Common Stock 41.8046.10
Payments for Repurchase of Common Stock 0023.66
Net Cash Provided by (Used in) Financing Activities 23.5323.0042.4889.57-0.97-7.10-7.95-14.34
Cash and Cash Equivalents, Period Increase (Decrease) 9.150.7115.0653.40-38.16-30.6316.1911.10-20.4710.56